- Case report
- Open Access
Polycystic subdural hygroma associated with immunoglobulin G4-related intracranial hypertrophic pachymeningitis: a case report
BMC Neurology volume 20, Article number: 228 (2020)
Recent studies have examined hypertrophic pachymeningitis as an IgG4-RD. However, there are no reports of immunoglobulin G4 (IgG4)-related hypertrophic pachymeningitis with polycystic subdural hygroma.
A 56-year-old man presented to the hospital with complaints of a persistent, pulsatile, occipital headache and general malaise. Magnetic resonance imaging of the brain revealed hypertrophic pachymeningitis with polycystic subdural hygroma and hematoma. Based on the dural biopsy findings and exclusion of other diseases, the patient was diagnosed with immunoglobulin G4 (IgG4)-related hypertrophic pachymeningitis. IgG4-related diseases may cause subdural hygroma more commonly than other diseases that cause hypertrophic pachymeningitis.
This is the first case report discussing polycystic subdural hygroma and hematoma with IgG4-related hypertrophic pachymeningitis.
Immunoglobulin G4-related disease (IgG4-RD) was first reported as hyper-IgG4emia in autoimmune pancreatitis . In recent studies, the hypertrophic pachymeningitis spectrum has also been included in IgG4-RDs [2,3,4]. Several studies have been conducted to examine the clinical and imaging features of IgG4-related hypertrophic pachymeningitis [2,3,4]. However, there are no reports of IgG4-related hypertrophic pachymeningitis with polycystic subdural hygroma. This is the first case report of a polycystic subdural hygroma and hematoma with IgG4-related hypertrophic pachymeningitis.
A 56-year-old man with a history of asthma, sinusitis, serous otitis media, idiopathic eosinophilia, recurrent idiopathic myocarditis, and idiopathic interstitial pneumonia was treated with prednisolone (PSL) at a dose of 27.5 mg/day. He had no symptom with steroid therapy. He complained of a persistent, pulsatile, occipital headache, and general malaise 2 weeks before admission, when the dose of PSL was reduced from 27.5 mg/day to 22.5 mg/day. However, he did not exhibit symptoms such as fever, weight loss, joint pain, rash, or diarrhea. A neurological examination revealed paralysis of the left abducens nerve. Magnetic resonance imaging (MRI) of the brain showed polycystic subdural hygroma and hematoma. In addition, with contrast enhancement, a diffuse thickening of the dura mater was observed (Fig. 1). Whole-body computed tomography (CT) scans showed no signs of lymphadenopathy or malignant tumors. Gallium scintigraphy revealed diffuse accumulation in the kidneys; however, there was no accumulation in the lymph nodes and joints. Urinalysis showed a tubular defect (N-acetyl-beta glucosamines 45 IU/L, beta-2-microglobulin 9156 μg/L), suggesting interstitial nephritis. Microbial analyses and immunologic bioassays were uninformative. There was no complement consumption or eosinophilia. His serum IgG4 level was slightly increased (126 mg/dL) at the PSL dose of 22.5 mg/dL. However, one year prior to the study, it was higher (332 mg/dL), although the dose of PSL was 7 mg/day. Craniotomy was performed from the left side of the head with a burr hole, made a dural incision, and collected a sample. After biopsy and dural suture, it was confirmed that was no leakage of spinal fluid by the Valsalva test, preventing low intracranial pressure syndrome from occurring. Dural biopsy confirmed that the dura was 2 mm thick, and its surface was red and edematous, and very fragile. Histopathological examination of the surgical specimen revealed a fibro-inflammatory lesion in the thickened dura due to lymphoplasmacytic infiltrates. Immunohistochemical analysis showed lymphocytic infiltration, 60 IgG4+ plasma cells per high-power field, and an IgG4+/IgG ratio greater than 50% (Fig. 2). There was no evidence of a malignant tumor, histiocytic disease, or granulomatous disease. Staining for microbial pathogens was negative. We established a diagnostic of IgG4-RD based on clinical diagnostic criteria [5, 6], we established a diagnosis of IgG4-RD; the unexplained multiple organ disorders (as mentioned before) also suggested IgG4-RD. The symptoms improved quickly with oral PSL therapy (45 mg/day, 0.6 mg/kg/day) after 2 courses of methylprednisolone 1 g pulse therapy for 3 days, and the subsequent brain MRI showed complete regression of meningeal thickening, polycystic subdural hygroma, and hematoma. Thereafter, tacrolimus (3 mg/day) was added, and the PSL dose was reduced by 2.5–5 mg every two weeks to a final dose of 10 mg/day. The patient had no recurrence of headache with oral treatment using PSL (10 mg/day) and tacrolimus (3 mg/day), and his serum IgG4 level decreased to 9.6 mg.
Discussion and conclusions
Intracranial hypertrophic pachymeningitis rarely accompanies subdural hygroma or hematoma. Only three cases have been reported in the literature [7, 8], including our case, of which two cases involved a diagnosis of IgG4-RDs. Until now, there have been no reports of IgG4-RDs associated with polycystic subdural hygroma or hematoma. In our case, exudative retention due to strong inflammation of the dura may have caused reactive film formation bleeding from the capsule or bridging vein . The dura adhesion may indicate that the exudate enters the space between the membranes and forms a cyst. In conclusion, we suggest that IgG4-RDs may often cause subdural hygroma.
Availability of data and materials
The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.
Immunoglobulin G4-related disease
Magnetic resonance imaging
Hematoxylin and eosin
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.
Yonekawa T, Murai H, Utsuki S, Matsushita T, Masaki K, Isobe N, et al. A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry. 2014;85:732–9.
Cação G, Calejo M, Alves JE, Medeiros PB, Vila-Cha N, Mendonça T, et al. Clinical features of hypertrophic pachymeningitis in a center survey. Neurol Sci. 2019;40:543–51.
Melenotte C, Sequier J, Ebbo M, Kaphan E, Bernit E, Saillier L, et al. Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: from a national case registry and literature review. Semin Arthritis Rheum. 2019;49:430–7.
Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.
Miyazaki H, Tabuse M, Ishiyama N, Kikuchi R, Ogihara T, Nanki K. A case of multifocal fibrosclerosis presenting with chronic subdural hematoma. Brain and Nerve. 2011;63:795–9.
He Z, Ding F, Rong J, Gan Y. A case of idiopathic hypertrophic cranial pachymeningitis presenting as chronic subdural hematoma. J Zhejiang Univ (Med Sci). 2016;45:540–3.
We would like to thank Editage ( www.editage.com ) for English language editing.
Consent to participate
The patient provided consent for participation in the study.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
The authors report no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ota, K., Nakazato, Y., Okuda, R. et al. Polycystic subdural hygroma associated with immunoglobulin G4-related intracranial hypertrophic pachymeningitis: a case report. BMC Neurol 20, 228 (2020). https://doi.org/10.1186/s12883-020-01815-z
- Hypertrophic pachymeningitis
- IgG4-related disease
- Polycystic hygroma